Trexquant Investment’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,446
Closed -$152K 1914
2023
Q1
$152K Sell
10,446
-11,475
-52% -$162K ﹤0.01% 1357
2022
Q4
$160K Sell
21,921
-11,512
-34% -$81.2K ﹤0.01% 1280
2022
Q3
$231K Buy
33,433
+1,685
+5% +$12.6K 0.01% 1131
2022
Q2
$222K Sell
31,748
-5,142
-14% -$40.1K 0.01% 1300
2022
Q1
$305K Buy
36,890
+25,986
+238% +$234K 0.01% 993
2021
Q4
$118K Sell
10,904
-8,276
-43% -$89.4K 0.01% 1221
2021
Q3
$231K Buy
+19,180
New +$216K 0.02% 884

Trexquant Investment's AMYT Position: Q2 2023 in Review

Trexquant Investment sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 10,446 shares — an estimated $152K sold.

Trexquant Investment first reported a position in AMYT in Q3 2021 and held it in 7 quarters. The position peaked at $305K in Q1 2022. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Trexquant Investment reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Trexquant Investment sold 10,446 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $152K.
  • Trexquant Investment first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2021 and held it in 7 quarters.
  • Trexquant Investment's Amryt Pharma plc American Depositary Shares position peaked at $305K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Trexquant Investment's 13F filing for Q2 2023, filed 11 Aug 2023.